Founded by recognized leaders in intrathecal therapies, CNS Therapeutics developed and brought to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. CNS was acquired by Covidien in 2012.
Total raised: $10M
Investors 1
| Date | Name | Website |
| - | InterWest ... | interwest.... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 10.01.2011 | - | $3M | - | medcitynew... |
| 27.08.2009 | - | $7M | - | medcitynew... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 10.01.2011 | Minnesota ... | Promoted Telemedicine’s poten... | - | - | medcitynew... |
| 27.08.2009 | Minnesota’... | Promoted Clinical Care Capaci... | - | - | medcitynew... |
| - | Minnesota ... | On the heels of FDA approval o... | - | - | medcitynew... |
| - | Minnesota’... | WOODBURY, Minnesota — The earl... | - | - | medcitynew... |